Stock Analysis of Odonate Therapeutics (ODTC) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ODTC
Close 1.50
Change 0 / 0 %
Volume 1867.00
Vol Change -7527.00 / 80.13 %
IndustryShell Companies
SectorFinancial Services
AIO Strength Index
Technical StrengthNeutral
Growth Index Low Growth Stock
Value Index Low Value Stock
Profitability Index Poor Profitability Stock
Stability Index No Significant Stability


Fundamental View of Odonate Therapeutics


Highs/Lows of Odonate Therapeutics
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week1.5 0 % 2.06 % 1.81.507-Sep-2307-Sep-23
Two Week1.53 1.96 % 2.52 % 1.81.507-Sep-2307-Sep-23
One Month1.52 1.32 % 3.83 % 1.81.507-Sep-2307-Sep-23
Three Month1.8 16.67 % 11.60 % 1.81.507-Sep-2307-Sep-23
Six Months1.8 16.67 % 15.26 % 2.421.501-May-2307-Sep-23
One year1.5 0 % 27.52 % 2.421.501-May-2307-Sep-23
Two year3.37 55.49 % 15.82 % 2.420.80801-May-2301-Aug-22
Five year18.63 91.95 % 81.86 % 2.420.80801-May-2301-Aug-22


Technical View of Odonate Therapeutics






Charts of Odonate Therapeutics


Returns of Odonate Therapeutics with Peers
Period / StockODTCGGAAJGGCRCLFSUNL
1 Week0%-49.79%-79.95%-5.76%-37.50%
1 Mth-1.32%-8.30%-67.74%10.76%-44.51%
3 Mth-16.67%2.56%-83.99%-74.61%-50.98%
6mth-16.67%4.13%-83.79%-73.14%-44.07%
1 Year0%7.76%-83.20%-72.28%-79.34%
2 Year-55.49%-71.81%-95.77%
5 Years-91.95%0%0%


Compare Fundamentals of Odonate Therapeutics with Peers
Ratio / StockODTCGGAAJGGCRCLFSUNL
PE-0.53733.0017.70-3131.08-22.20
P/B0.4861.080.114221.1518.33
ROA-69.523.030.614-5.43-73.45
ROE-90.646.941.730-134.19
Debt To Equity0.0048-0.141000.168
Revenue0
%
0
%
0
%
0
%
98506.00 K
14.15 %
Net Income-126350.00 K
12.99 %
3972.35 K
3731.33 %
5615.20
114.05 %
11039.07 K
613.86 %
-315851.00 K
105.87 %


Technicals of Odonate Therapeutics with Peers
Technical / StockODTCGGAAJGGCRCLFSUNL
ADX54.0580.6342.2421.8128.38
CMF0.075-0.497-0.600-0.393-0.409
MFI14.0997.0528.5792.3024.28
RSI43.9746.5331.8931.3629.39
MACD Abv SignalFalseTrueFalseFalseTrue
Price Above 50 MAFalseFalseFalseFalseFalse
Price Above 200 MAFalseTrueFalseFalseFalse


About : Odonate Therapeutics


Address : 3 East 28th Street, New York, NY, United States, 10016
Tel : 332 206 0935
URL : https://www.odonate.com
Code : ODTC, ISIN : US6760791060, Exchange : PINK, Country : USA
Fiscal Year End : December
IPO date : 07_Dec_2017
Employee Count : 137

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.


Note : All Data Generated at the End of Trading Hours (EOD Data)